Addex Therapeutics Stock Investor Sentiment
| ADXN Stock | USD 8.83 0.17 1.89% |
About 59% of Addex Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Addex Therapeutics suggests that many traders are alarmed. Addex Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Addex Therapeutics. Many technical investors use Addex Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Addex Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Addex Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Addex Therapeutics' Stock prices. Below is the latest headlines and news related to Addex Therapeutics Stock. The global stock market is bearish. About 68% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Addex Therapeutics that are available to investors today. This information is accessible both publicly - through Addex Therapeutics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Addex-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Addex Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Addex Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Addex Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Addex Therapeutics alpha.
Addex Largest EPS Surprises
Earnings surprises can significantly impact Addex Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-04 | 2021-09-30 | -0.8527 | -0.723 | 0.1297 | 15 | ||
2021-05-05 | 2021-03-31 | -0.6565 | -0.5256 | 0.1309 | 19 | ||
2021-08-05 | 2021-06-30 | -0.7876 | -0.9263 | -0.1387 | 17 | ||
2022-03-10 | 2021-12-31 | -0.6492 | -0.8151 | -0.1659 | 25 | ||
2023-05-11 | 2023-03-31 | -0.0516 | -0.2684 | -0.2168 | 420 | ||
2022-05-05 | 2022-03-31 | -0.5163 | -0.9136 | -0.3973 | 76 |
There is far too much social signal, news, headlines, and media speculation about Addex Therapeutics that are available to investors today. This information is accessible both publicly - through Addex Therapeutics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Addex-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Addex Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Addex Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Addex Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Addex Therapeutics alpha.
Addex Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Addex Therapeutics Reports 2024 Financial Results and Strategic Developments - TipRanks | 04/24/2025 |
2 | Addex Therapeutics Earnings Call Strategic Gains Amid Financial Challenges - TipRanks | 04/28/2025 |
3 | Addex Therapeutics Partners with Sinntaxis for Brain Injury Treatment ADXN Stock News - GuruFocus | 04/30/2025 |
4 | Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference - marketscreener.com | 06/04/2025 |
5 | Addex Therapeutics to Announce Q1 2025 Financial Results and Corporate Update - TipRanks | 06/17/2025 |
6 | Trading Resumes for Addex Therapeutics ADXN Stock News | 06/20/2025 |
7 | Addex Therapeutics Invests in Staliclas Autism Drug Development | 06/30/2025 |
Check out Addex Therapeutics Hype Analysis, Addex Therapeutics Correlation and Addex Therapeutics Performance. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.52) | Revenue Per Share | Quarterly Revenue Growth (0.70) | Return On Assets | Return On Equity |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.